Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SSAO inhibitor-3 (Compound 2) can be used in the study of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, multiple sclerosis, etc. SSAO inhibitor-3 is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC 50 s of 0.1-10 μM and <10 nM for human AOC1 and SSAO, respectively [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 491,500 |
50 mg | 約6-8 週間 | ¥ 639,500 |
100 mg | 約6-8 週間 | ¥ 808,000 |
説明 | SSAO inhibitor-3 (Compound 2) can be used in the study of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, multiple sclerosis, etc. SSAO inhibitor-3 is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC 50 s of 0.1-10 μM and <10 nM for human AOC1 and SSAO, respectively [1]. |
分子量 | 326.37 |
分子式 | C15H23FN4O3 |
CAS No. | 2671028-09-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SSAO inhibitor-3 2671028-09-2 Inhibitor inhibitor inhibit